The year 2020 has proven to be a defining year for the medical and biopharmaceutical fields across the world. Since the first half of the year, many countries across the world have been plagued with the COVID-19 pandemic.
Researchers from Statens Serum Institut (SSI), Denmark, and Imperial College London have published promising results from the first clinical trial of a vaccine for Chlamydia, the most common sexually transmitted disease.